Literature DB >> 10676431

New vistas for melanocortins. Finally, an explanation for their pleiotropic functions.

F L Strand1.   

Abstract

This paper presents a historical overview of melanocortin (MC) research from the early investigations of the many noncorticotropic effects of peptide fragments of adrenocorticotropic hormone to the present focus on the discovery and cloning of the MC receptors (MCRs). Final acceptance of the passage of neuropeptides through the blood-brain barrier provided the scientific basis for the neuropeptide concept, formulated previously by both De Weid and Kastin, that peripherally administered neuropeptides affect neural processes. The discussion includes melanocortin effects on behavior, the cardiovascular system, central and peripheral electrophysiological parameters, food intake, inflammation and analgesia, nerve regeneration and neuroprotection, and development. The localization of specific MCRs in both neural and nonneural tissues is correlated with the pleiotropic effects discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10676431     DOI: 10.1111/j.1749-6632.1999.tb07874.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  The effect of semax on animal pain sensitivity in various experimental models.

Authors:  D M Ivanova; N G Levitskaya; L A Andreeva; L Yu Alfeeva; A A Kamenskii; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2003 Jan-Feb

2.  The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo.

Authors:  O V Dolotov; T S Seredenina; N G Levitskaya; A A Kamensky; L A Andreeva; L Yu Alfeeva; I Yu Nagaev; Yu A Zolotarev; I A Grivennikov; Yu Engele; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2003 Jul-Aug

3.  The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system.

Authors:  N G Levitskaya; E A Sebentsova; L A Andreeva; L Yu Alfeeva; A A Kamenskii; N F Myasoedov
Journal:  Neurosci Behav Physiol       Date:  2004-05

4.  Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone.

Authors:  Catharina Lindberg; Erik Hjorth; Claes Post; Bengt Winblad; Marianne Schultzberg
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

5.  Signal Cloaking by Electric Fish.

Authors:  Philip K Stoddard; Michael R Markham
Journal:  Bioscience       Date:  2008       Impact factor: 8.589

6.  The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study.

Authors:  Vasily V Stavchansky; Vadim V Yuzhakov; Alexandra Yu Botsina; Veronika I Skvortsova; Lyubov N Bondurko; Marina G Tsyganova; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova
Journal:  J Mol Neurosci       Date:  2010-07-09       Impact factor: 3.444

7.  The proprotein convertase encoded by amontillado (amon) is required in Drosophila corpora cardiaca endocrine cells producing the glucose regulatory hormone AKH.

Authors:  Jeanne M Rhea; Christian Wegener; Michael Bender
Journal:  PLoS Genet       Date:  2010-05-27       Impact factor: 5.917

8.  Melanocortins regulate the electric waveforms of gymnotiform electric fish.

Authors:  Michael R Markham; Susan J Allee; Anna Goldina; Philip K Stoddard
Journal:  Horm Behav       Date:  2008-11-21       Impact factor: 3.587

9.  Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats.

Authors:  Nava Naveh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-30       Impact factor: 3.117

10.  A rapid MALDI-TOF mass spectrometry workflow for Drosophila melanogaster differential neuropeptidomics.

Authors:  Joseph P Salisbury; Kristin J Boggio; Yun-Wei A Hsu; Jeniffer Quijada; Anna Sivachenko; Gabriele Gloeckner; Paul J Kowalski; Michael L Easterling; Michael Rosbash; Jeffrey N Agar
Journal:  Mol Brain       Date:  2013-12-27       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.